Amedeo's Top 20

Amedeo Smart

Independent Medical Education

03 October 2022

Multidisciplinary Journal Club

  1. Nathan DM, Lachin JM, Bebu I, Burch HB, et al.
    Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
    N Engl J Med 2022;387:1075-1088.

  1. Bhatt DL, Vaduganathan M, Kandzari DE, Leon MB, et al.
    Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
    Lancet 2022.

  2. Ailani J, Kaiser EA, Mathew PG, McAllister P, et al.
    Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine-Clinical Considerations: A Narrative Review.
    Neurology 2022.

  3. Gottesman RF, Wu A, Coresh J, Knopman DS, et al.
    Associations of Vascular Risk and Amyloid Burden with Subsequent Dementia.
    Ann Neurol 2022;92:607-619.

  4. di Filippo L, Castellino L, Allora A, Frara S, et al.
    Distinct clinical features of post COVID-19 vaccination early-onset Graves' disease (PoVEO GD).
    J Clin Endocrinol Metab 2022.

  1. De Gottardi A, Sempoux C, Berzigotti A.
    Porto-sinusoidal vascular disorder.
    J Hepatol 2022;77:1124-1135.

  2. Linde LR, Readhead A, Barry PM, Balmes JR, et al.
    Tuberculosis Diagnoses Following Wildfire Smoke Exposure in California.
    Am J Respir Crit Care Med 2022.

  3. Broocks G, Heit JJ, Kuraitis GM, Meyer L, et al.
    Benefit of Intravenous Alteplase Before Thrombectomy Depends on ASPECTS.
    Ann Neurol 2022.

  4. Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, et al.
    The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
    Blood 2022;140:1229-1253.

  5. Di Blasi R, Le Gouill S, Bachy E, Cartron G, et al.
    Outcomes of patients with aggressive B-Cell lymphoma after failure of anti-CD19 CAR T-Cell Therapy: A DESCAR-T analysis.
    Blood 2022.

  1. Kudrow D, Nguyen L, Semler J, Stroud C, et al.
    A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene-related peptide ligand (galcanezumab) or receptor (erenumab) antagonist.
    Headache 2022.

  2. Chappuis M, Rousseau C, Bajeux E, Wiertlewski S, et al.
    Discontinuation of second- versus first-line disease-modifying treatment in middle-aged patients with multiple sclerosis.
    J Neurol 2022.

  3. Gisselbrecht C, Sibon D.
    Do we have to exclude all relapsed diffuse large B-cell lymphoma patients not in complete remission from autologous stem cell transplant?
    Br J Haematol 2022.

  4. Stoupa A, Kariyawasam D, Quoc AN, Polak M, et al.
    APPROACH TO THE PATIENT WITH CONGENITAL HYPOTHYROIDISM.
    J Clin Endocrinol Metab 2022.

  5. Katz TA, van Kaam AH, Schuit E, Mugie SM, et al.
    Comparison of new bronchopulmonary dysplasia definitions on long term outcomes in preterm infants.
    J Pediatr 2022.

  1. Shapiro SD, Vazquez S, Das A, Dominguez JF, et al.
    Investigating Outcomes Post Endovascular Thrombectomy in Acute Stroke Patients With Cancer.
    Neurology 2022.

  2. Lin JY, Yeh LL, Pan YJ.
    Exposure to psychotropic medications and mortality in schizophrenia: a 5-year national cohort study.
    Psychol Med 2022.

  3. McKinley SK, Brady MS.
    Neoadjuvant therapy for melanoma: A critical appraisal.
    J Surg Oncol 2022.

  4. Bundred JR, Michael S, Stuart B, Cutress RI, et al.
    Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis.
    BMJ 2022;378:e070346.

  5. Man V, Luk WP, Fung LH, Kwong A, et al.
    The role of pre-operative axillary ultrasound in assessment of axillary tumor burden in breast cancer patients: a systematic review and meta-analysis.
    Breast Cancer Res Treat 2022.


more..

Privacy Policy